2013
DOI: 10.1111/iwj.12162
|View full text |Cite
|
Sign up to set email alerts
|

Angiosome‐targeted revascularisation in diabetic foot ulcers

Abstract: Peripheral vascular disease is a common complication of type 2 diabetes and is often more severe and diffuse than in non-diabetic individuals with a higher risk of major amputations in the lower limbs. Diabetic foot revascularisation using both traditional bypass surgery and endovascular therapy are often burdened by the failure and the inevitable subsequent massive amputation. In this study, we examined the clinical response of diabetic patients with critical limb ischaemia and extended ischaemic wounds, trea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
21
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
10

Relationship

4
6

Authors

Journals

citations
Cited by 26 publications
(21 citation statements)
references
References 28 publications
0
21
0
Order By: Relevance
“…Critical lower limb ischaemia (CLI) is a common disease that usually results from progressive narrowing of the arteries caused by atherosclerosis . Severe ischaemic pain, claudication, tissue loss and finally limb amputation are common complications of peripheral arterial disease (PAD), especially among patients affected by diabetes mellitus and end‐stage renal disease and on haemodialysis . The common treatment of PAD includes correction of risk factors, medical therapy and revascularisation through endovascular treatment or distal bypass, in order to restore a pulsatile flow as distal as possible .…”
Section: Introductionmentioning
confidence: 99%
“…Critical lower limb ischaemia (CLI) is a common disease that usually results from progressive narrowing of the arteries caused by atherosclerosis . Severe ischaemic pain, claudication, tissue loss and finally limb amputation are common complications of peripheral arterial disease (PAD), especially among patients affected by diabetes mellitus and end‐stage renal disease and on haemodialysis . The common treatment of PAD includes correction of risk factors, medical therapy and revascularisation through endovascular treatment or distal bypass, in order to restore a pulsatile flow as distal as possible .…”
Section: Introductionmentioning
confidence: 99%
“…When bacteria invade into host cells, antibacterial drugs cannot effectively enter the cells. The compromised anti-infection effects result in delayed wound healing and cause great suffering in patients (18). The results of this study showed that the susceptibility of pathogens to conventional antibacterial drugs have declined year by year from 2013 to 2016, which was closely related to the unreasonable use of antibacterial drugs.…”
Section: Discussionmentioning
confidence: 99%
“…With such aims, predictive indices and risk‐stratification of patients with CLI can guide the physician in choosing and tailoring the treatment of PAD. This is even more valiant when newer and ancillary approaches to PAD such as angiosome‐targeted revascularisation , extreme distal bypass , gene therapy , vacuum‐assisted closure (VAC) therapy , spinal cord stimulation and prostaglandin E1 infusions are considered.…”
Section: Discussionmentioning
confidence: 99%